(Q77309343)
Statements
Incidence, outcome and prediction of early clinical events following percutaneous transluminal coronary angioplasty. A comparison between treatment with reviparin and unfractionated heparin/placebo (results of a substudy of the REDUCE trial) (English)
M B Preisack
R Bonan
C Meisner
V Eschenfelder